TITLE

Anti-prostate Antibodies in Arthritis

AUTHOR(S)
Grimble, A.; Lessof, M. H.
PUB. DATE
July 1965
SOURCE
British Medical Journal;7/31/1965, Vol. 2 Issue 5456, p263
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64059593

 

Related Articles

  • Anti-keratin antibodies in rheumatoid arthritis. Young, B.J.J.; Mallya, R.K.; Leslie, R.D.G.; Clark, C.J.M.; Hamblin, T.J. // British Medical Journal;7/14/1979, Vol. 2 Issue 6182, p97 

    Examines the occurrence of anti-keratin antibodies in patients with rheumatoid arthritis. Detection of the antibody; Diagnosis of patients with rheumatoid arthritis; Treatment of rheumatoid arthritis.

  • Arthritis wonder cure wins cautious welcome. Webb, Jeremy // New Scientist;2/12/94, Vol. 141 Issue 1912, p16 

    Discusses the discovery of an antibody to the tumor necrosis factor (TNF) which aims to reduce the pain and stiffening associated with arthritis. Results of study on the administration of anti-TNF antibody on 20 patients; Biochemistry of rheumatoid arthritis.

  • Women's Antibodies To Chlamydia May Offer Protection.  // Arthritis Today;Nov/Dec2001, Vol. 15 Issue 6, p27 

    Presents the results of a study that discovered the significance of women's antibodies to the bacterium Chlamydia trachomatis in reducing the risks of reactive arthritis. Background on reactive arthritis; Comparison on the risks of reactive arthritis for men and women; Implications.

  • anti-cyclic citrullinated peptide antibodies.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p147 

    A definition of the medical term "anti-cyclic citrullinated peptide antibodies," which refers to antibodies found in the serum of patients with rheumatoid arthritis, is presented.

  • SLE precipitated by antibodies in a patient with Sjogren's syndrome and rheumatoid arthritis.  // British Medical Journal;11/15/1975, Vol. 4 Issue 5993, p385 

    Examines the association of systemic lupus erythematosus (SLE) antibodies on patients with Sjogren's syndrome and rheumatoid arthritis. Development of SLE after antibiotic and co-trimoxazole intake for rheumatoid arthritis; Precipitation of antibiotics on SLE; Distinction of rheumatoid...

  • Rheumatoid Arthritis.  // Current Medical Literature: Rheumatology;2006, Vol. 25 Issue 4, p101 

    The article presents medical research on rheumatoid arthritis. They include "Diagnostic and Predictive Value of Anti-Cyclic Citrullinated Protein Antibodies in Rheumatoid Arthritis: A Systematic Literature Review," "Effects of Abatacept in Patients With Methotrexate-Resistant Active Rheumatoid...

  • Reactive arthritis associated with Campylobacter jejuni enteritis. Berden, J.H.M.; Muytjens, H.L.; van dePutte, L.B.A. // British Medical Journal;2/10/1979, Vol. 1 Issue 6160, p380 

    Examines the association of Campylobacter jejuni arteritis in patient with reactive arthritis. Isolation of Campylobacter jejuni in the feces; Increase of antibody titer against Campylobacter jejuni; Development of acute arthritis following onset of enteritis.

  • Golimumab. Pappas, Dimitrios A.; Bathon, Joan M.; Hanicq, Delphine; Yasothan, Uma; Kirkpatrick, Peter // Nature Reviews Drug Discovery;Sep2009, Vol. 8 Issue 9, p695 

    Golimumab (Simponi; Centocor Ortho Biotech), a fully human antibody that is specific for tumour necrosis factor, was approved by the US FDA for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in April 2009.

  • Cambridge Antibody Technology plc: Interim results for the six months ended 31st March, 2004. Aaronson, Colin // Journal of Commercial Biotechnology;Oct2004, Vol. 11 Issue 1, p97 

    The article presents information related to Cambridge Antibody Technology Group PLC (CAT). CAT has established itself as a leader in the development of human monoclonal antibodies as new treatments for disease, based upon its own antibody technology. One of its drugs is used for the treatment...

  • ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis. Matsos, Mark P.; Pope, Janet E.; Spencer-Green, George // Inflammopharmacology;2004, Vol. 12 Issue 3, p229 

    Assesses the susceptibility of rheumatoid factor (RF) positive patients with rheumatoid arthritis to develop the manifestations of connective tissue diseases and auto-antibodies. Characteristics of patients for RF; Association between RF values and anti-nuclear antibodies.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics